Cargando…
Anakinra Hepatotoxicity in a Patient With Adult-Onset Still's Disease
We report a 46-year-old white woman with adult-onset Still's disease (AOSD) treated with anakinra, a IL-1B receptor antagonist. Within weeks, her liver enzymes deteriorated; subsequent cessation and rechallenge confirmed anakinra-related drug-induced liver injury (DILI). Although AOSD has been...
Autores principales: | Ahmed, Osman, Brahmania, Mayur, Alsahafi, Majid, Alkhowaiter, Saad, Erb, Sig |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Gastroenterology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435404/ https://www.ncbi.nlm.nih.gov/pubmed/26157954 http://dx.doi.org/10.14309/crj.2015.45 |
Ejemplares similares
-
Pulmonary Arterial Hypertension in Adult-Onset Still's Disease: Rapid Response to Anakinra
por: Campos, Marc, et al.
Publicado: (2012) -
Macrophage Activation Syndrome Associated with Adult-Onset Still's Disease Successfully Treated with Anakinra
por: Kumar, Aswini, et al.
Publicado: (2016) -
Adult-onset Still’s disease: Switch to atypical skin manifestations under anakinra therapy
por: Klapproth, Henning, et al.
Publicado: (2023) -
Anakinra and hepatotoxicity in pediatric rheumatology: a case series
por: Martins, Frederico Rajão, et al.
Publicado: (2023) -
Anakinra in children and adults with Still’s disease
por: Vastert, Sebastiaan J, et al.
Publicado: (2019)